|
This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Cervidil (Dinoprostone Vaginal). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view all available reports.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (8)
Cases resulting in a serious event (8)
Cases resulting in life threatening events (2)
Cases resulting in hospitalization (6)
Cases resulting in disability (2)
Cases resulting in other serious reactions (5)
Adverse event in 26 year old female receiving Cervidil (Dinoprostone Vaginal)
Reported by a consumer/non-health professional from United States on 2007-07-20
Patient: 26 year old female
Adverse reactions / side effects: Rubella Antibody Positive, Inappropriate Schedule of Drug Administration, Drug Dose Omission, Drug Exposure During Pregnancy, Heart Rate Increased, Amniocentesis Abnormal, Pregnancy
Suspect drug(s):
Cervidil
Claravis
Dosage: 40 mg, bid, oral
Administration route: Oral
Start date: 2006-02-07
End date: 2006-08-13
Ortho TRI-Cyclen LO
Dosage: 1 tablet, qd, oral
Administration route: Oral
Indication: Oral Contraception
Other drugs received by patient: Chitosan (Poliglusam); Isotrim (Sulfamethoxazole, Trimethoprim); Vita-PAK
Adverse event in 30 year old female receiving Cervidil (Dinoprostone Vaginal)
Reported by a individual with unspecified qualification from United Kingdom on 2007-07-06
Patient: 30 year old female, weighing 71.5 kg (157.3 pounds)
Adverse reactions / side effects: Postpartum Haemorrhage, Caesarean Section, Apgar Score LOW, Body Temperature Increased, Drug Exposure During Pregnancy, Foetal Heart Rate Deceleration, Uterine Atony, Foetal Heart Rate Abnormal, Tachycardia Foetal
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Cervidil (Dinoprostone Vaginal)
Other drugs received by patient: Zolpidem Tartrate; Tylenol (Caplet); Intravenous Fluids; Epidural OR Regional Anesthesia; Oxygen
Adverse event in male receiving Cervidil (Dinoprostone Vaginal)
Reported by a individual with unspecified qualification from United Kingdom on 2007-07-06
Patient: male, weighing 2.5 kg (5.4 pounds)
Adverse reactions / side effects: Apgar Score LOW, Caesarean Section, Drug Exposure During Pregnancy, Foetal Heart Rate Disorder, PRE-Eclampsia, Tachycardia Foetal
Adverse event resulted in: hospitalization
Suspect drug(s):
Cervidil
Dosage: 10 mg once transplacental
Indication: Labour Induction
Start date: 2006-12-27
End date: 2006-12-27
Cervidil
Dosage: 10 mg once transplacental
Indication: Uterine Cervix Dilation Procedure
Start date: 2006-12-27
End date: 2006-12-27
Other drugs received by patient: Zolpidem Tartrate; Tylenol (Caplet); Intravenous Fluids; Epidural OR Regional Anesthesia; Oxygen
Adverse event in 30 year old female receiving Cervidil (Dinoprostone Vaginal)
Reported by a individual with unspecified qualification from United Kingdom on 2007-06-27
Patient: 30 year old female, weighing 71.5 kg (157.3 pounds)
Adverse reactions / side effects: Placental Infarction, Uterine Atony, Haemoglobin Decreased, Caesarean Section, Haematocrit Decreased, Drug Exposure During Pregnancy, NO Therapeutic Response, Surgical Failure, PRE-Eclampsia
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Cervidil (Dinoprostone Vaginal)
Other drugs received by patient: Zolpidem Tartrate; Tylenol (Caplet)
Adverse event in female receiving Cervidil (Dinoprostone Vaginal)
Reported by a health professional (non-physician/pharmacist) from France on 2007-06-04
Patient: female
Adverse reactions / side effects: Vomiting, Nuclear Magnetic Resonance Imaging Brain Abnormal, Meningism, Postictal State, Convulsion, Reversible Posterior Leukoencephalopathy Syndrome, Drug Exposure During Pregnancy, Tetanus, Tongue Biting, Musculoskeletal Stiffness
Adverse event resulted in: hospitalization
Suspect drug(s):
Cervidil
Dosage: 10 mg once vg
Indication: Uterine Cervix Dilation Procedure
Start date: 2007-02-09
Syntocinon
Indication: Labour Induction
Start date: 2007-02-09
Other drugs received by patient: Salbutamol
Adverse event in female receiving Cervidil (Dinoprostone Vaginal)
Reported by a individual with unspecified qualification from United Kingdom on 2007-05-23
Patient: female
Adverse reactions / side effects: Reversible Posterior Leukoencephalopathy Syndrome, Nuclear Magnetic Resonance Imaging Brain Abnormal, Meningism, Convulsion
Adverse event resulted in: hospitalization
Suspect drug(s):
Cervidil
Dosage: 10 mg once vg
Indication: Cervix Disorder
Start date: 2007-02-09
Syntocinon
Indication: Labour Induction
Start date: 2007-02-09
Other drugs received by patient: Salbutamol
Adverse event in female receiving Cervidil (Dinoprostone Vaginal)
Reported by a health professional (non-physician/pharmacist) from Canada on 2007-03-09
Patient: female
Adverse reactions / side effects: Caesarean Section, Drug Exposure During Pregnancy, Premature Separation of Placenta
Adverse event resulted in: hospitalization
Suspect drug(s):
Cervidil (Dinoprostone Vaginal)
Adverse event in female receiving Cervidil (Dinoprostone Vaginal)
Reported by a health professional (non-physician/pharmacist) from Canada on 2007-03-09
Patient: female
Adverse reactions / side effects: Premature Separation of Placenta
Suspect drug(s):
Cervidil (Dinoprostone Vaginal)
|
